- Joined
- Oct 4, 2017
- Messages
- 5,042
- Reaction score
- 9,842
I am not sure that is in iba’s interest.If IBA or these other places were smart, they’d do what pharma does and start sponsoring trials.
we all know the results would be devastating to the companies. Their best strategy is to promote registry trials and give grants to certain academics cited above. kick the can down the road and someone else will be there to pick up the pieces when we face deligitimization.
Last edited: